Mercury Biopharmaceutical Corporation (6932.TWO)

TWD 13.3

(-2.56%)

Long Term Debt Summary of Mercury Biopharmaceutical Corporation

  • Mercury Biopharmaceutical Corporation's latest annual long term debt in 2023 was 41.66 Million TWD , down -1.65% from previous year.
  • Mercury Biopharmaceutical Corporation's latest quarterly long term debt in 2024 Q1 was 41.5 Million TWD , down -0.42% from previous quarter.
  • Mercury Biopharmaceutical Corporation reported annual long term debt of 42.36 Million TWD in 2022, up 3370.02% from previous year.
  • Mercury Biopharmaceutical Corporation reported annual long term debt of 1.22 Million TWD in 2021, down 0.0% from previous year.
  • Mercury Biopharmaceutical Corporation reported quarterly long term debt of 41.42 Million TWD for 2024 Q2, down 0.0% from previous quarter.
  • Mercury Biopharmaceutical Corporation reported quarterly long term debt of 41.66 Million TWD for 2023 Q3, down -0.41% from previous quarter.

Annual Long Term Debt Chart of Mercury Biopharmaceutical Corporation (2023 - 2019)

Historical Annual Long Term Debt of Mercury Biopharmaceutical Corporation (2023 - 2019)

Year Long Term Debt Long Term Debt Growth
2023 41.66 Million TWD -1.65%
2022 42.36 Million TWD 3370.02%
2021 1.22 Million TWD 0.0%
2020 - TWD 0.0%
2019 - TWD 0.0%

Peer Long Term Debt Comparison of Mercury Biopharmaceutical Corporation

Name Long Term Debt Long Term Debt Difference
Allied Biotech Corporation 72.02 Million TWD 42.147%
GeneFerm Biotechnology Co., Ltd. 76.14 Million TWD 45.281%
Easywell Biomedicals, Inc. 330.44 Million TWD 87.39%
TTY Biopharm Company Limited 403.04 Million TWD 89.662%
Synmosa Biopharma Corporation 1.45 Billion TWD 97.143%
Orient EuroPharma Co., Ltd. 2.2 Billion TWD 98.109%
Center Laboratories, Inc. 4.42 Billion TWD 99.059%
Tien Liang BioTech Co., Ltd. 377 Thousand TWD -10952.52%
Orient Pharma Co., Ltd. 323.73 Million TWD 87.129%
InnoPharmax Inc. 5.38 Million TWD -673.635%
Johnson Chemical Pharmaceutical Works Co., Ltd. 100.83 Million TWD 58.675%
Excelsior Biopharma Inc. 300.25 Million TWD 86.122%
DV Biomed Co., Ltd. 315.74 Million TWD 86.803%
Foresee Pharmaceuticals Co., Ltd. 13.11 Million TWD -217.713%
Handa Pharmaceuticals, Inc. 7.67 Million TWD -443.189%
UniPharma Co., Ltd. - TWD -Infinity%
Anxo Pharmaceutical Co., Ltd. 499.69 Million TWD 91.661%
Alar Pharmaceuticals Inc. 138 Thousand TWD -30094.203%
Winston Medical Supply Co., Ltd. 56.05 Million TWD 25.669%
Bioray Biotech Co., Ltd 65.65 Million TWD 36.535%
TSH Biopharm Corporation Limited - TWD -Infinity%